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Abstract: Kenya is home to Africa’s third largest population of dromedary camels, and production 
at commercial and local levels are increasingly important. In pastoral and nomadic communities in 
the arid and semi-arid lands (ASALs), camels play a vital role in food security, while commercial 
milk production and formalized export markets are rapidly emerging as camel populations expand 
into non-traditional areas. Until recently, little focus was placed on camels as hosts of zoonotic 
disease, but the emergence of Middle Eastern respiratory coronavirus (MERS-CoV) in 2012, and the 
discovery of exposure to the virus in Kenyan camels, highlighted the need for further understanding 
of this area. This systematised review utilised a robust search strategy to assess the occurrence of 
camel-associated zoonoses in Kenya and to evaluate the quality of the published literature. Seventy-
four studies were identified, covering sixteen pathogens, with an increasing number of good quality 
studies in recent years. Despite this, the area remains under-researched and there is a lack of robust, 
high-quality research. Trypanosome spp., Echinococcus granulosus and Brucella spp. appeared most 
frequently in the literature. Pathogens with the highest reported prevalence were MERS-CoV (0–
100%), Echinococcus granulosa (7–60%) and Rift Valley fever virus (7–57%). Exposure to Brucella spp., 
Coxiella burnetii and Crimean-Congo haemorrhagic fever virus showed higher levels in camel or 
camel-associated vectors than other livestock species, although brucellosis was the only disease for 
which there was robust evidence linking camel and human exposure. Zoonotic agents with less 
severe human health outcomes, such as Dermatophilosus congolensis and contagious ecthyma, were 
also represented in the literature. This review provides an important summary of the scope and 
quality of current knowledge. It demonstrates that further research, and improved adherence to 
robust study design and reporting are essential if the zoonotic risk from camels in Kenya, and 
elsewhere, is to be better understood. 
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1. Introduction 
Kenya is home to Africa’s third largest population of one-humped, dromedary camels (Camelus 
dromedarius) and they account for approximately 5% of the country’s livestock [1]. Camel production 
has long played a vital role in nomadic and pastoral communities, but formalised production, aimed 
primarily at lucrative urban milk markets, as well as a thriving international export market, are 
increasingly important [2–5]. Camels are unique amongst livestock species in their ability to thrive in 
arid environments, providing an important source of food and financial security to vulnerable 
communities, particularly in the face of climate instability [6–8]. Camel keeping in Kenya was 
traditionally focussed in pastoral communities in the arid and semi-arid lands (ASALs) in the 
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northern and north-eastern regions, but as interest in camel production and awareness of their value 
in food security has developed, populations have expanded into non-traditional areas such as Isiolo 
and Laikipia; a move supported by the Kenyan government’s ‘2030 vision’ [7,9,10]. 
Perhaps due to their capacity to thrive in harsh environments, camels were previously 
considered resistant to many diseases common in other production animals [11,12]. However, the 
expansion of camel production has led to a re-evaluation of traditional assumptions regarding the 
species’ susceptibility to disease [13,14], and the emergence of Middle Eastern respiratory syndrome 
coronavirus (MERS-CoV) in Saudi Arabia in 2012 brought their potential as a zoonotic reservoir into 
sharp focus [15,16]. Zoonotic pathogens, both in Kenya and globally, disproportionally affect the 
poorest communities, who tend to live in closer proximity to livestock and often have limited access 
to medical and veterinary services [17,18]. The benefits of a One Health approach to zoonotic disease 
control, particularly in poor and isolated communities, has become well established in Kenya over 
the last decade, but research has tended to focus on cattle and small ruminants [19,20]. As camel 
production expands, opportunities for zoonotic transmission events are likely to increase. 
Developing a better understanding of potential zoonotic hazards is an important first step towards 
reducing the frequency and impact of these events. In light of these concerns, a systematic evaluation 
of the literature was undertaken to assess the occurrence of zoonotic pathogens associated with 
dromedary camels in Kenya, and the scope of the published literature. The aims of the review were 
to evaluate the scope and quality of the literature, as well as to collate prevalence and strain-typing 
data, with a view to identifying gaps in current knowledge and priorities for future research. 
2. Materials and Methods 
2.1. Search Strategy and Record Assessment 
A systematised review of the literature was carried out, taking into consideration the guidelines 
set out in the PRISMA statement, and by adapting best-practice guidelines and protocols developed 
by other systematic review reporting systems [21–26]. Nine databases and collections relating to 
medical and veterinary disease, global health and basic science were searched to provide a 
comprehensive assessment of published literature (CAB abstracts, Global Health, Medline, PubMed, 
Web of Science, BIOSIS, EMBASE, Zoological Record and Africa-Wide Information). Searches 
covered publications up to the end of December 2017. Grey literature, including media articles and 
unpublished government reports were excluded due to difficulties in verifying their contents, and 
comprehensively searching for them. 
Zoonotic infections of camels deemed likely to be of relevance in Kenya were determined 
through review of camel health and production literature, literature relating to zoonoses of other 
livestock species in East Africa, and the Kenyan Government Zoonotic Disease Unit’s list of priority 
zoonoses [27]. Only pathogens that could cause clinical disease in humans and be transmitted via 
human/camel contact, close association such as via aerosol or fomite spread, or by vector transmission 
were included. This excluded most food-borne pathogens including Escherichia coli and Salmonella 
species. 
Search terms defining the population, location and disease exposure were combined using the 
Boolean operator “AND”, and Boolean syntax was adapted to the requirements of the different 
databases. Terms relating to population included “camel/camels” and “dromedary/dromedaries”. 
Location terms used were “Kenya” and “Kenyan.” For disease terms, “zoono*” was combined using 
the Boolean operator ‘OR’ with terms relating to individual zoonotic diseases of camels. Trypanosoma 
species (spp.) were included due to recent evidence of the zoonotic potential of Trypanosoma evansi 
[28–30]. Population, location and disease searches were combined using the Boolean operator 
“AND”. A full list of diseases identified, and the basic search terms used are presented in Table 1. 
Search terms and inclusion criteria were reviewed by both authors prior to commencement of 
searches, and review was undertaken by the first author only. 
Citations were compiled in EndNoteTM and duplicate entries removed. Remaining titles and 
abstracts were subject to three levels of review: (i) title and abstract review, (ii) full-text review and 
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(iii) quality review. At each stage, citations, abstract or full-text papers were included or excluded 
according to predefined criteria (Supplementary Materials, Figures S1 and S2). Data were extracted 
from the remaining full-text citations using a standard data extraction form and the details entered 
into Microsoft Excel (2016). Where citations were published in more than one location, the more 
recent or more complete citation was selected. During the full-text review, reference lists of relevant 
papers were searched by hand and additional papers added. 
Table 1. Search terms and synonyms used to construct searches relating to zoonotic pathogens of 
camels in Kenya.  
Zoonotic Infections/Agents of Relevance Search Terms and Synonyms (* Indicates Wildcard Search Function) 
Brucella spp. “brucel *” 
Camelpox “camelpox”, “pox” “poxvir *”, “orthopox *” 
Crimean-Congo haemorrhagic fever virus “Crimean-Congo haemorrhagic fever *”  
Echinococcus granulosa sensu lato “echinococ *”, “* hydatid *” 
Emerging pathogens “emerging” AND “infection *” OR “virus *” OR “bacteria *” 
Middle Eastern respiratory syndrome virus 
“Middle East respiratory”, “Middle Eastern respiratory”, 
“MERS”, “MERS-CoV”, “coronavir *” 
Q fever (Coxiella burnetii) “q fever *”, “coxiell *” 
Rift Valley fever virus “Rift Valley fever”, “RVF” 
Sarcoptes “sarcopt *”, “mange *” 
Toxoplasmosis “toxoplasma *” 
Trypanosome spp. “* trypanos *”, “African trypan *”  
Tuberculosis “TB”, “tubercul *”, “mycobact *” 
Wildcard functions (denoted by an *) were used to expand the search terms where appropriate. Search 
terms and wildcard functions were adapted as required for each database. 
2.2. Quality Criteria Assessment 
The quality criteria set out in Alonso et al. [24] were used to assess the level of bias in the full-
text review papers. An adapted version of the Alonso et al. criteria is presented in Table 2. All papers, 
regardless of quality designation were included in the qualitative review and discussion. For the 
purposes of presenting quantitative data on prevalence, only data from papers deemed to be of 
medium or good quality were reported [24]. 
Table 2. Quality criteria tool used to assess the level of bias in studies selected for inclusion in the 
review. Adapted from [24]. 
Good Quality (Low Risk of 
Bias) 
Medium Quality (Moderate Risk of 
Bias) 
Poor Quality (High Risk of 
Bias) 
Unbiased selection of subjects, 
evidence of randomisation 
Bias in subject selection is 
acknowledged and accounted for or is 
unavoidable 
Bias in subject selection is not 
acknowledge or accounted for 
Appropriate data analysis 
Data analysis limitations are 
acknowledged 
Inappropriate data analysis 
Scientifically sound methods 
Methods are sound but may not be the 
most appropriate 
Methods are inappropriate 
Accurately described methods 
Methods are comprehensible and valid 
even if details are lacking 
Methods are unclear or 
incomplete 
Accurate and complete 
reporting of results 
Results are reported accurately 
Results are inaccurate or 
incomplete 
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3. Results 
3.1. Summary 
Following the three stages of review, 74 unique studies were identified as fitting all pre-defined 
criteria (Supplementary Materials, Figures S1 and S2). The PRISMA flow diagram, showing the 
numbers of references identified and removed at each stage, is shown in Figure 1. 
 
Figure 1. PRISMA flowchart showing numbers of studies at each stage of the review [31]. 
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Twenty-four papers (32.4%) were deemed to be of poor quality, 41 (55.4%) medium and nine 
(12.2%) of good quality. All but one of the good quality studies were published since 2000, with a 
trend towards an increasing proportion of good or medium quality publications and a decrease in 
poor quality studies over the course of the review (Figure 2). 
 
Figure 2. Percentage of total studies per decade categorised as good, medium or poor quality based 
on the criteria set out by Alonso et al. [24]. 
Sixteen pathogens, or genera of pathogens, were identified: thirteen in camel hosts, four in ticks 
retrieved from camels, and two camel-specific strains of pathogen identified in humans (Table 3). 
Eight viruses, five bacteria, one protozoa, one fungus and one endoparasite were identified. The 
largest number of papers (n = 29, 39.2%) dealt with trypanosome species, with the next most 
frequently reported pathogens being Echinococcus spp. (n = 9, 12.2%) and Brucella spp. (n = 7, 9.5%). 
Five studies were published before 1980, with between 16 and 20 studies published in each decade 
since. Zoonotic potential was specifically mentioned in 29 papers (39.1%) and an increase in such 
studies was observed since 2010, with all papers since this date highlighting zoonotic risk (Figure 3). 
Forty-two studies dealt with disease surveillance (56.8%), with the majority of these employing a 
cross-sectional design to determine prevalence. 
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Figure 3. Total number of studies published by decade, showing the number of publications that 
highlighted the zoonotic risk of the pathogen and those that did not. 
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Table 3. Zoonotic pathogens of dromedary camels in Kenya: number of studies identified in this review and host species in which it was identified. 
Pathogen or Disease Number of Studies 
Host or Vector of the Pathogen Identified 
References 
Quality Score 
Camel Tick † Human ‡ Good Medium Poor 
Viruses 
MERS-CoV 4 X  X [32,33] [34,35]  
Rift Valley fever virus 4 X    [36,37] [38,39] 
Camelpox 4 X    [40,41] [42,43] 
Crimea-Congo haemorrhagic fever virus 2 X X   [44,45]  
Contagious ecthyma 2 X    [46,47]  
Dugbe virus 1  X   [48]  
Dhori virus 1  X   [48]  
Influenza viruses (ICV and IDV) 1 X    [49]  
Bacteria 
Coxiella burnetii (Q fever) 3 X    [50,51] [52] 
Dermatophilus congolensis 5 X    [53] [54–57] 
Brucella spp. 7 X   [58] [59] [12,60–63] 
Mycobacterium spp. 1 X     [60] 
Rickettsia spp. 1  X   [64]  
Parasites and Fungi 
Trypanosoma spp. 28 X   [65–69] [10,70–83] [84–92] 
Echinococcus spp. 10 X  X [93] [94–102]  
Trichophyton verrucosum 1 X    [53]  
† Ticks removed from Dromedary camel hosts only. ‡ Evidence of transmission from camels to human, or of a camel-specific strain of pathogen in human hosts. 
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Prevalence figures reported in medium- and good-quality papers are reproduced in Table 4. 
Strain typing and pathogen characterisation was the focus of 17 (23.0%) studies and diagnostic test 
development or validation accounted for 13 (17.6%) publications. The remaining studies included 
treatment trials, risk evaluations, disease impact and disease outbreak investigations or case studies. 
Half of identified papers (n = 37) referred to a county level location. Figure 4 shows the number of 
studies by county. 
 
Figure 4. Number of published studies on zoonotic pathogens of camels in Kenya by county. 
3.2. Viruses 
Half the zoonotic hazards identified were viruses, with MERS-CoV, Rift Valley fever (RVF) virus 
(RVFV) and camelpox the most commonly described (Table 3). MERS-CoV was the focus of four 
eligible good- and medium-quality papers between 2014 and 2017. All publications described cross-
sectional studies to determine current or historic serological exposure to MERS-CoV in camels or 
humans, with the most recent study examining exposure in linked camel and human populations 
[33]. Prevalence estimates in camels ranged from 6.1% to 100% depending on diagnostic method, age 
and location [33–35]. Liljander et al. found 0.18% of humans tested positive for MERS-CoV specific 
antibodies, but no humans sampled in the linked household study were positive by the same 
diagnostic method (Table 4) [32,33]. RVF was also the focus of four papers, two of poor and two of 
medium quality (Table 3). Early evidence indicated that RVFV was the cause of camel abortions 
during the 1961–1962 epidemic, confirming the presence of the virus in the arid northern counties 
[38,39]. Both medium-quality papers demonstrated high seroprevalence during the 2006–2007 
epidemic, with Britch et al. [37] also reporting a pre-epidemic prevalence of approximately 7% (Table 
4). Camelpox was the focus of four studies, with two of medium quality. One reported a cross-
sectional survey (Table 4), and one employed a variety of laboratory techniques to characterise two 
strains of Kenyan camelpox [40,41]. No studies have been published on camelpox in Kenya since 1997 
[40]. Contagious ecthyma, caused by a parapox virus [103,104], was reported in camels in two 
medium quality studies. One reported on an outbreak of clinical disease in Laikipia in 1984 [47], while 
the other presented results of a cross-sectional survey in Turkana (Table 4) [46]. 
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Crimean-Congo haemorrhagic fever virus (CCHFV) was the focus of two studies, both of 
medium quality. One found evidence of exposure in camels imported from Kenya to Egypt [45] 
(Table 4), while the second used reverse transcription PCR (RT-PCR) to screen ticks collected from 
livestock in north-eastern Kenya in 2008 [44,45]. Five tick pools were positive for CCHFV (1.4%) [44]. 
Morrill. et al. also tested samples for antigenically related Nairoviruses, including Dugbe virus [105], 
which was also detected in ticks from camels in Garissa and Isiolo in a survey of tick-borne viruses 
between 2007 and 2010 [45,48]. Nine percent of tick pools positive for Dugbe virus came from camel 
hosts. Dhori virus, a zoonotic orthomyxovirus, was identified in ticks pooled from a camel in Isiolo, 
and Kupe virus, which is of unknown pathogenicity in humans, was detected in the same study 
[48,106,107]. A single paper investigating the seroprevalence of Influenza D and C viruses (IDV and 
ICV) in livestock found antibodies to one or other of the viruses in almost all Kenyan camels sampled, 
with evidence of cross-reactivity between IDV and ICV (Table 4) [49]. 
3.3. Bacteria 
Five bacterial pathogens associated with camel hosts were identified (Table 3). Brucella spp. were 
reported in seven eligible papers, covering ten counties, between 1978 and 2015 (Table 3). All studies 
reported serological evidence of exposure, with a single study examining seropositivity in humans 
and livestock [108]. Two papers reporting cross-sectional surveillance were of medium or good 
quality (Table 4) [59,108]. Exposure to Coxiella burnetii, the causative agent of Q fever, was the focus 
of three eligible studies (Table 3). One paper, of poor quality, identified four positive camels in 
Samburu [52] and two medium quality studies investigated prevalence in camels in Laikipia in 2011 
and 2013 [50,51]. Skin conditions caused by Dermatophilus congolensis were reported in five studies in 
Laikipia, Samburu and Turkana counties, one of which was of medium quality [53]. The presence of 
five Rickettsia species in ticks removed from camels was reported in a single cross-sectional study in 
pastoralist areas of Garissa and Isiolo counties [64]. Sixty percent of positive tick pools were collected 
from camels, compared to 31% from cattle, 17% from sheep and 14% from goats. A single study, 
deemed to be of poor quality, indicated the presence of Mycobacteria spp. in camels ranched between 
Tana River and Kilifi Counties [60]. Fifteen camels (36.6%) reacted following the intradermal skin test 
and acid-fast bacteria were detected on impression smears from a single lung lesion. 
3.4. Parasites and Fungi 
One endoparasite, one protozoa and one fungi were identified in the literature (Table 3). Cystic 
echinococcus, caused by the dog tapeworm Echinococcus granulosus sensu lato (s.l.) was reported in 
ten studies. Where county location was specified, all but one focussed on Turkana [98]. One study 
reported only human infection while all other studies reported infection in camels and other livestock 
species [99]. Eight studies presented strain or genetic typing evidence (Table 5), while cross-sectional 
disease surveillance data were presented in two publications (Table 4) [98,102]. All studies were of 
medium or good quality. Studies concerned various species and strains of E. granulosus sensu lato. 
The categorisation of E. granulosus has changed considerably over the period of the review and three 
different categorisation systems are represented in the eligible papers (Table 5). Trypanosoma spp. 
were the focus of the largest number of studies (n = 28). All papers investigated the presence of 
Trypanosoma brucei-type (trypanozoon) organisms and 26 confirmed T. evansi specifically. Although 
one study specified a potential zoonotic risk from T. evansi, no typanosome species responsible for 
typical human African trypanosomiasis (HAT) were identified. A single study presented evidence of 
mixed infections with Dermatophilus congolensis and Trichophyton verrucosum, a zoonotic 
dermatophyte fungal pathogen [53]. 
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Table 4. Prevalence values reported in disease surveillance studies categorised as good or medium quality, based on criteria set out in Alonso et al. 2016 [24]. 
Type Pathogen Species Dates 
Sampled 
Test Used Number 
Tested 
County or 
Region 
Prevalence 
% (95% CI) † 
Quality Reference 
Virus 
Middle Eastern 
respiratory 
coronavirus 
(MERS-CoV) 
Camel 1992–2013 
Recombinant MERS-CoV spike 
protein subunit 1-based ELISA 
(rELISA) described by Memish et al., 
2014 [109] 
162 
North-eastern 
region 
56.2 
Medium [34] 154 Eastern region 17–100 
458 
Rift Valley 
region 
0–18 
Camels 2013 
Spike protein subunit 1 protein 
microarray [110,111] 
335 
Laikipia 
county 
46.9 Medium [35] 
Camels 
2013 
AntiMERS-CoV Camel IgG ELISA kit 
(EUROIMMUN AG, Lübeck, 
Germany) 
879 
Marsabit 
county 
90 (95% CI 
88–92) 
Good [33] 
Humans 
AntiMERS-CoV Camel IgG ELISA kit 
(EUROIMMUN AG, Lübeck, 
Germany) followed by plaque 
reduction neutralisation test (PRNT) 
[112] 
760 
Marsabit 
county 
0 
Humans 2013–2014 
rELISA (EUROIMMUN AG, Lübeck, 
Germany) followed by PRNT [112] 
559 Garissa county 0 
Good [32] 
563 
Tana River 
county 
0.36 
Crimean-Congo 
haemorrhagic fever 
virus 
Camels 1986–1987 Agar gel diffusion (AGD) test [113] 499 Not specified 26 Medium [45] 
Contagious 
ecthyma 
Camels 
Not 
specified 
Clinical examination and electron 
microscopy 
600 Turkana 11.2 Medium [46] 
Rift Valley fever 
virus 
Camels 
2006–2007 
(epidemic 
period) 
In-house IgG ELISA [114] 110 Not specified 20.9 Medium [36] 
Camels 
2000 (pre-
epidemic 
period) 
In-house inhibition ELISA [115] 
15 Galana county 6.7 
Medium [37] 
13 Garissa county 7.7 
2007 
(epidemic 
period) 
28 Isiolo county 57.1 
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Camelpox Camels 1992 
Clinical examination, electron 
microscopy, virus neutralisation 
1000 
Samburu 
county 
27 
Medium [40] 
1200 
Turkana 
county 
6 
Influenza D virus 
(IDV) 
Camels 2015 
Hemagglutination inhibition (HI), 
post-ICV hemadsorption 
293 Not specified 8.2 Medium [49] 
Influenza C virus 
(ICV) 
Camels 2015 HI, post-IDV hemadsorption 293 Not specified 10.6 Medium [49] 
Bacteria 
Brucella spp. 
Camels 
Not 
specified 
Rose Bengal plate test (RBPT) 
174 
Warir, Garissa 
and Mandera 
counties 
4.6 
Medium [59] Serum agglutination test (SAT) 10.34 
Complement fixation test (CFT) 9.77 
Camels 2013 
Brucella-Ab C-ELISA kit 
(SVANOVIR, Uppsala, Sweden) 
1605 
Marsabit 
county 
11.1 (95% CI 
9.4–15.0) 
Good [108] 
Coxiella burnetii (Q 
fever) 
Camels 2011 
ELISA CHEKIT Q fever test kit 
(IDEXX, Westbrook, ME, USA 
72 
Laikipia 
county 
Adults  
(3–9 years) 
46 
Young  
(<6 m) 
5 
Medium [50] 
Camels 2013 
ELISA CHEKIT Q fever test kit 
(IDEXX, Hoofddorp, The 
Netherlands) 
334 
Laikipia 
county 
19 Medium [51] 
Dermatophilus 
congolensis 
Camels 1993 
Clinical examination and bacterial 
isolation 
3200 
Samburu 
county 
Wet season, 
20.9 
Dry season, 
13.6 
Medium [53] 
600 
Laikipia 
county 
Wet season, 
22.7 
Dry season, 
14.3 
Parasites 
Echinococcus spp. 
Camels 1998–2000 Post-mortem examinations 70 
Turkana 
county 
60.1 Medium [102] 
Camels 2013 
Post-mortem examination and RFLP-
PCR [98] 
219 
Meru and 
Isiolo counties 
6.94 Medium [98] 
Trypanosoma spp. Camels 1996–1997 
Haematocrit centrifugation technique 
(HCT) 
Mouse inoculation test (MIT) 
103 
Athi River 
(Machakos 
county) 
2.9 (95% CI 
0–6.2) 
Medium [73] 
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Suratex® latex agglutination test 
(Brentec Diagnostics, Nairobi, Kenya) 
[71] 
749 Isiolo county 
25.4 (95% CI 
22.3–28.5) 
86 
Mugwoni 
(Laikipia 
county) 
18.6 (95% CI 
10.4–26.8) 
Camels 
Not 
specified 
Phase contrast buffy coat technique 
(BCT) 
MIT 
347 
Kajiado 
county 
33.8 Medium [10] 
† 95% confidence intervals (95% CI) only reproduced here if reported in the original study. 
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Table 5. Echinococcus granulosus sensu lato characterised according to the nomenclature set out in each 
paper to describe strain, species and genotype, with host species and diagnostic method reported. 
Echinococcus granulosus 
Species/Genotype 
Host 
Species Method of Confirmation County/Location Reference 
E. granulosus  
Type B Camel 
Electrophoresis: isoelectric 
focusing Turkana [97] 
E. granulosus  
Type A Human 
Electrophoresis: isoelectric 
focusing Turkana [97] 
E. granulosus  
‘Common sheep strain’ 
Camel PCR and electrophoresis Turkana [100] 
E. granulosus  
‘Camel strain’  
Camel PCR and electrophoresis Turkana [100] 
E. granulosus G1 
Camel 
Humans 
PCR Turkana/Maasai [116] 
E. granulosus G6 (G6/7) 
Camel 
Human 
PCR Turkana/Maasai [116] 
E. granulosus G1 Human PCR Turkana [99] 
E. granulosus G6 Human PCR Turkana [99] 
E. granulosus sensu stricto 
(s.s.) 
Camel PCR Meru/Isiolo [98] 
E. canadensis (formally G7) Camel PCR Meru/Isiolo [98] 
E. Canadensis G6/7 cluster 
Camels 
Human 
PCR Not specified [93] 
4. Discussion 
This review documented evidence of 16 zoonotic pathogens in dromedary camels in Kenya. The 
pathogens with the highest reported prevalence in camel populations were MERS-CoV, Echinococcus 
granulosa s.l. and RVFV, while Brucella spp., Coxiella burnetii and CCHFV showed higher levels in 
camels or camel-associated vectors than other livestock species (Table 4). Brucellosis was the only 
pathogen for which robust evidence was identified linking camels with increased human disease risk, 
although a lack of evidence for this link in other pathogens may be due to insufficient research rather 
than an absence of association [108].  
4.1. Trends in Camel Research 
Livestock census and aerial estimates indicate that camel populations have expanded over the 
last 30 years and the increasing importance of camel production to the Kenyan economy is widely 
accepted [14,117–119]. In contrast, publication numbers of eligible studies remained broadly similar 
in each decade since the 1980s, indicating that camel zoonoses research in Kenya has not increased in 
line with population expansion [120,121]. However, the proportion of papers that explicitly referred 
to zoonotic risk have shown a substantial increase since 2010 (Figure 2), suggesting an increasing 
importance placed on this dynamic. The proportion of studies characterised as medium or good 
quality also increased over the period of the review (Figure 2), which may in part reflect the 
emergence of veterinary epidemiology as a distinct field of study. Prior to the most recent decades, 
nearly half of identified publications were of poor quality, with small sample sizes, a lack of clear 
sampling frame, or incomplete reporting of results preventing many studies from providing robust 
estimates of prevalence, even where these figures were recorded. A propensity towards poor-quality 
research in zoonotic disease studies has been identified elsewhere, and deserves greater attention at 
research and government level to improve the quality of camel studies in general, and of camel 
zoonoses in particular [24]. It is vital that high-quality research is available to enable policy makers 
and other stakeholders to make appropriate decisions about zoonotic disease priorities, controls and 
preventions. 
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4.2. Study Locations 
The location of studies partly reflects the distribution of camel populations, with more studies 
focusing on counties in the northern regions of the country (Figure 4). However, research location 
was dominated by Laikipia, despite it being a non-traditional camel keeping area. The semi-arid 
county is one of the most important in Kenya for wildlife and has a mixture of large commercial 
ranches, wildlife conservancy and pastoralist lands [122]. It is easily accessible compared to counties 
further north and has a history of livestock research and improvements, which may account for its 
overrepresentation in the literature [50]. In addition, the Laikipia camel population is estimated to 
have increased by a factor of nearly five between 1982 and 2010 and is likely to keep expanding as it 
is also home to the country’s only large commercial camel dairy [50]. By contrast, counties such as 
Mandera and Wajir, which have both the highest camel populations and largest proportions of the 
population living under the poverty line, are under-represented in the literature [123]. Logistic and 
security issues may deter researchers from undertaking projects in these areas. Somali pastoralists 
and other communities in this region may be at greater risk of camel-associated zoonoses due to 
higher camel densities and poor access to medical and veterinary services. The lack of published 
research in these areas suggests that those who rely most heavily on camels for their health and 
livelihoods may be receiving the least benefit from current research. 
4.3. Viral Zoonoses 
MERS-CoV is the most prominent camel associated zoonosis worldwide and has caused more 
than 800 deaths since it emerged in Saudi Arabia in 2012 [124]. Dromedary camels are the principal 
reservoir host and several camel to human transmission events have been confirmed in the Middle 
East [125,126]. The papers identified in this review show strong evidence of high MERS-CoV 
seroprevalence in camels in northern and north-eastern Kenya and Laikipia County as far back as 
1983, suggesting the virus is endemic in the national herd [34,127]. This is consistent with studies 
from across the continent [111,127–130]. The first evidence of human exposure to MER-CoV in Sub-
Saharan Africa was reported in Tana River County by Liljander et al. in 2016 [32]. The human 
seroprevalence in this study was similar to that found in Saudi Arabia [112] and may suggest that 
human clinical cases are going unreported in Kenya. However, the lack of evidence for human 
seroconversion in households where camel herds had very high seroprevalence found by Munyua et 
al. in 2017 suggests camel to human transmissibility of MERS-CoV may be lower in Kenya compared 
to populations with similar camel exposure in the Middle East [33]. The mechanisms for this apparent 
difference in transmission risk remain unclear and the emergence of MERS-CoV in human 
populations in Kenya is still of concern [131,132].  
Rift Valley fever is a significant public health concern and is recognised as one of the top 
priorities for zoonotic disease research and control in Kenya [27,133]. Evidence of clinical disease and 
high levels of seroconversion in camels identified by this review suggest that camels may play an 
important role in amplification and maintenance of the virus [37,38]. Similar findings from other 
outbreaks across Africa support this theory, and suggest that camels may be particularly sensitive 
indicators of RVFV activity, in part due to their long-distance movements as well as their apparent 
sensitivity to the virus [39,134–136]. With raised awareness amongst pastoralist camel-keepers it is 
possible that camel abortion could act as an early warning of RVF virus infection [137]. Investigations 
into the potential role of camels in viral amplification and as sentinels are currently limited and this 
gap should be addressed in future studies. 
Camelpox virus is reportedly endemic in East Africa [138,139] and several studies that fell 
outside the inclusion criteria of this review reported clinical outbreaks or high seroprevalence 
[12,139]. These observations were rarely supported by robust study design or laboratory diagnosis, 
making assessment of the true burden difficult, while the zoonotic nature of camelpox is poorly 
understood and rarely cited [41]. No cases of human disease have been recorded in Kenya, although 
Davies et al. reported unconfirmed descriptions of humans developing ulcers on the lips and mouth 
following consumption of milk from visibly affected camels [41]. Early literature suggested that 
zoonotic transmission of the virus was rare and did not present a public health concern [138,140], but 
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more recently, verified human cases have led to a reassessment of its zoonotic potential [141–143]. In 
the post-smallpox world, with the emergence of a strain of zoonotic orthopox virus a possibility [144], 
further surveillance and epidemiological investigation of camelpox would be wise [141]. 
Crimean-Congo haemorrhagic fever virus (CCHFV) is a globally under-researched tick-borne 
virus with a high case-fatality rate in humans and potential for human-human transmission [145,146]. 
The first human infection in Kenya, a single acute case, was reported in 2002, and in 2012 a study in 
Ijara (now Garissa County) found a seroprevalence of 19% (95% CI 15–22%) in febrile patients 
presenting to local health facilities [145,147]. Hyalomma spp. ticks are the principal vectors and are 
found on all major livestock species in Kenya including camels [44,48]. The exact role of different 
livestock species remains unclear, but CCHFV positive ticks were only obtained from cattle and 
camels, suggesting these species may be involved in disease transmission and amplification. Camels 
may be a particularly important focus for research given their potential to transport infected ticks 
over long distances. 
Findings reported by Salem et al. suggest, for the first time, that camels appear to be hosts of 
Influenza C and possibly Influenza D viruses (ICV and IDV) [49]. ICV is a known human pathogen, 
typically causing mild disease in young patients and has been found in other mammalian species 
including pigs and domestic dogs, while the host tropism of IDV is less well understood [148–150]. 
Although cross-reactivity between the two viruses made estimates of true prevalence difficult to 
determine, the evidence presented by Salem et al. gives reason to further investigate the role of camels 
in the tropism of these viruses [49]. 
4.4. Bacterial Zoonoses 
Brucellosis is one of the most widespread and significant bacterial zoonoses worldwide, causing 
severe disease in humans and livestock, as well as imposing a substantial economic burden [151,152]. 
Serological evidence of Brucella exposure in camels was first reported in Kenya in 1978 but despite a 
prevalence of approximately 10%, no further studies investigated the pathogen in camels until 2012 
[59,61,63]. The study conducted by Osoro et al. in 2015 is worthy of note as the only paper reviewed 
to find an explicit link between camel exposure and increased odds of human seroprevalence [108]. 
Human studies indicate that the burden of disease in camel-producing regions is high. A study in 
remote hospitals in Garissa and Wajir found that 13.7% febrile patients were positive for Brucella 
abortus and contact with multiple animal species was significantly associated with infection [151]. 
Evidence of association between humans and animals in the same household demonstrates the value 
to be gained from a One Health approach, and the association with camel ownership suggests that a 
potential source of Brucella infection may be overlooked in typical studies focusing on cattle and small 
ruminants [108,153]. Similar studies, investigating how human interactions with camels influence 
zoonotic disease risk, should be prioritised. The findings of this review also indicate that Coxiella 
burnetii, the causative agent of Q fever, may be another neglected bacterial zoonosis of camels in 
Kenya. C. burnetii exposure is widespread amongst livestock and humans in the country but is poorly 
understood and under-reported [154]. Only two recent studies have investigated C. burnetii in 
Kenyan camels but the significantly higher camel seroprevalence compared to cattle found by 
Browne et al. [50] is consistent with findings from elsewhere in Africa [155]. 
A number of other bacterial pathogens were identified. Dermatophilus congolensis causes 
exudative dermatitis in multiple species and is typically associated with tick and biting fly-
transmission, although it can also be spread by contact [156–159]. Prevalence levels were similar in 
Kenya to Sudan and Iran, at between 12 and 30%, and were significantly higher during the wet season 
[53,160,161]. This may indicate an increased risk as camel production moves into areas with higher 
rainfall. Human cases are reported sporadically in the medical literature, but none have been reported 
in Kenya [157,162,163]. The typically self-limiting presentation of the disease in humans is likely to 
mean that cases go unreported. However, disease can be more serious and debilitating in certain 
individuals, so health professionals working with livestock keepers should remain vigilant [164]. 
Rickettsia spp. were identified from various species of ticks in Garissa and Isiolo counties and 
although full numbers were not reported, significantly more Rickettsia positive tick pools came from 
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camel-associated ticks than other livestock hosts [64]. Despite evidence of circulation of several 
zoonotic Rickettsia spp. in Kenya, few acute human clinical cases have been recorded [165–167]. 
However, the lack of distinct clinical features as well poor access to laboratory diagnostics means 
febrile illness caused by Rickettsia spp. is likely under-reported [64,168]. Further surveillance is 
required to develop a fuller picture of the true prevalence and range of Rickettsia spp. in camel ecto-
parasite populations, and the impact of these on human disease risk. The identification of 
mycobacteria infections in camels, although only identified in one study [60], may be of public health 
importance as Mycobacterium bovis cases have been reported in camels elsewhere in Africa and 
nomadic communities in Kenya appear to have higher levels of tuberculosis than the general 
population [169,170]. Although the reasons behind these high infection rates are poorly understood, 
it is hypothesised to relate to consumption of infected milk. Given the nutritional and economic 
importance of camel milk for many Kenyan pastoralists, further research on the presence of zoonotic 
Mycobacterium species in camels, particularly in these vulnerable communities, is recommended 
[118,119]. 
4.5. Parasitic Zoonoses 
Extensive research into cystic echinococcosis (CE), caused by species of the canine tapeworm 
Echinococcus granulosa s.l., has been undertaken in Kenya, and studies in this review demonstrate the 
presence of E. granulosa s.l. and E. canadensis in camel populations in Turkana, Meru and Isiolo 
counties. Studies tended to focus on strain typing and cyst viability rather than prevalence due to a 
lack of reliable and cost-effective diagnostic tests for screening large numbers of animals under field 
conditions [102,171]. Human infections, both worldwide and in Kenya, are dominated by genotype 
type G1 (‘common sheep strain’), now categorized as E. granulosus sensu stricto (s.s.) [172]. Although 
prevalence levels appear to be high in Kenya and neighbouring countries, the dominance of the 
‘G6/G7’ genotype (now re-categorized as a distinct species, Echinococcus canadensis) in camel 
populations may suggest that this species plays a lesser role in human CE [93,173,174]. However, a 
review of 1661 human cases globally found that 11% of these were caused by ‘G6/G7’ genotype, and 
a study of animal and human cases in Sudan found that E. canadensis was the dominant cause of 
human infections [175,176]. These findings suggest that E. canadensis may play a more important role 
in human infection in Kenya than is currently recognised. Historically, research focussed almost 
exclusively on Turkana County, where unusually high levels of CE are found in the human 
population [177,178]. Prevalence of Echinococcus spp. in camels in Turkana was comparable to that 
seen in other species, but a slaughter slab study in Isiolo and Meru counties, where levels of CE in 
the human population are much lower, found camels to have higher levels of infection compared to 
cattle, sheep and goats [98,102]. The dominance of Turkana as a focus of research may mean that the 
causes and dynamics of infection in other areas of the country are overlooked. 
The greatest number of eligible studies dealt with Trypanosoma spp., either identified specifically 
as T. evansi or more generally as T. brucei-type trypanosomes, which in camel hosts are most likely to 
be T. evansi. Trypanosomiasis, or Surra, caused by T. evansi is considered one of the most important 
production diseases of camels in East Africa [80,179] but camels are not known to be hosts of T. brucei 
gambiense or T. brucei rhodesiense, the species responsible for HAT. Trypanosomes were included in 
this review due to the recently highlighted zoonotic potential of T. evansi but only one study made 
explicit reference to this [68]. This is consistent with the assumption, until recently, that T. evansi was 
not zoonotic. The first reported case of zoonotic T. evansi infection occurred in an Indian farmer in 
2004 [180] and since then individual cases have been reported in Egypt and Vietnam [30,181]. Factors 
affecting the transmissibility of T. evansi to humans are not fully understood and the risk is likely to 
be very low [182]. However, given the importance of T. evansi as a production disease of camels, it is 
possible that occasional cases of human T. evansi infections occur in Kenya, but go unreported, and 
it’s zoonotic potential should not be ignored [29,183]. 
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4.6. ‘Missing’ Pathogens 
Several zoonotic pathogens of camels were notable by their absence. Sarcoptic mange, caused 
by the mite Sarcoptes scabii, has been listed as an important disease of camels in East Africa and was 
ranked as one of the top 15 priority zoonoses in Kenya, but no eligible papers referred to this 
pathogen [10,133]. Cases of mange were described in several studies but these were not included 
because the diagnosis was based on clinical examination only and not confirmed with appropriate 
laboratory methods, or because results were incompletely reported [10,88,92]. Studies utilising more 
robust diagnostic methods would help to characterise this disease risk. No publications were 
identified relating to Toxoplasma gondii, which is known to be an important disease of camels 
elsewhere and is an under-researched but likely important public health concern in Kenya [184]. A 
review and meta-analysis of toxoplasmosis in meat animals in Africa found camels to have the 
highest average prevalence at 36% (95% CI 18–56%) [185], and a study in Ethiopia found a prevalence 
in camels of 68.2% (95% CI: 63.5% to 72.9%) with the presence of cats or wild felids significantly 
associated with camel seropositivity [186]. With camel populations increasing in wildlife areas such 
as Laikipia, further research is needed to determine the significance of this pathogen. A recent 
publication identified for the first time a prion disease of dromedary camels in Algeria [187]. 
Although the distribution, and infectious and zoonotic risk of this pathogen is unknown, this 
discovery provides further evidence of the importance of enhanced surveillance and research into 
camel disease. 
4.7. Limitations 
The current review has certain limitations, in light of which the results should be viewed. The 
exclusion of food-borne pathogens omitted a number of important camel-associated zoonoses which 
would benefit from a comprehensive review, particularly in light of raw camel milk consumption 
practiced in some pastoral communities [188,189]. Although efforts were taken to construct 
comprehensive and replicable searches of the published literature, the exclusion of unpublished 
reports and other grey literature may mean instances of disease outbreaks have been missed. Efforts 
were made to standardize the quality review process by employing the methods set out in Alonso et 
al., but subjectivity in this assessment may have introduced a reporting bias [24,190]. To limit bias 
introduced from poor quality studies, prevalence estimates were only reproduced from medium- or 
good-quality papers. Although serology is an important tool in disease surveillance, seropositivity 
may not reflect current infection status or transmissibility of the pathogen. In addition, the number 
of identified studies does not necessarily reflect the pathogens with the highest prevalence in camels 
or those that pose the greatest zoonotic risk. No further statistical analysis of the reported data were 
undertaken, so it was not possible to draw conclusions about camel associated risk beyond those 
presented by individual publications. Despite these limitations, the evidence identified by this review 
provides a starting point for further research aimed at quantifying the risk to human populations 
from camel-associated zoonoses in Kenya. 
5. Conclusions 
The quality findings of this review and the imbalance of research focus are reflective of neglected 
tropical diseases on a wider scale, whose neglect is often driven by under-reporting and under-
estimation of true burden. Good-quality, robust studies on the prevalence, incidence or typing of 
zoonotic pathogens in camels were limited, and it is vital that camel and zoonotic disease researchers 
make robust study design and reporting a priority if data are to be useful for the broad interpretation 
required to inform policy. Where prevalence data were robustly reported, MERS was not the only 
pathogen to which camels were highly exposed, and these pathogens, as well as those to which 
camels appeared more exposed than other livestock species, point to priorities for further research. 
The number of studies which considered camel and human disease together was extremely limited, 
a situation also reflected in literature on other species in Kenya [191]. It remains to be seen whether 
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the increasing interest in One Health approaches to zoonotic disease research and control will 
increase the proportion of such studies in future.  
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